Kuang-Hua Chen

Title: Kuang-Hua Chen: Innovator in Cancer Treatment

Introduction

Kuang-Hua Chen is a notable inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of biomedical research, particularly in the development of innovative methods for cancer treatment.

Latest Patents

Chen holds a patent for a modified anthrax toxin protective antigen. This patent discloses a protective antigen (PA) comprising a PA amino acid sequence, wherein one or more of the amino acid residues I207, I210, E654, I656, R659, M662, Y681, and L687 are independently substituted. The patent specifies that amino acid residue I207 is not substituted with alanine and amino acid residue I210 is not substituted with alanine. Additionally, it includes related compositions, nucleic acids, recombinant expression vectors, host cells, populations of cells, methods of treating or preventing cancer in a mammal, and methods of inhibiting the growth of a target cell.

Career Highlights

Chen is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this prestigious institution has allowed him to focus on groundbreaking research that has the potential to impact cancer therapies significantly.

Collaborations

Some of his notable coworkers include Shi-Hui Liu and Stephen H. Leppla. Their collaborative efforts contribute to the advancement of research in the field of cancer treatment.

Conclusion

Kuang-Hua Chen's innovative work and patent in the field of cancer treatment highlight his dedication to improving healthcare outcomes. His contributions are invaluable to the ongoing fight against cancer.